Latest News

Quotient Sciences Wins Multiple Categories in 2023 CDMO Leadership Awards

Read Now

Search

15 results for "Candidate Selection"

Drug Substance

At a glance

Candidate Development

Navigating the Small Molecule CMC Pathway

Learn about drug substance and formulation considerations for improving downstream clinical outcomes. Access on demand.

Pharmaceutical CDMO & CRO | Quotient Sciences

Preformulation Screening

Oncology

Project Management at Quotient Sciences

Quotient is an innovative drug development and manufacturing partner supporting clients from candidate selection to commercial launch. With expertise in end-to-end Project Management and integrated project teams, we make drug development easier for our customers and dramatically reduce the time and cost of getting new medicines to patients.

Moving Drug Substance Off the Critical Path: Streamlined Strategies to Accelerate to First-in-Human & Beyond

Watch our on demand webinar to hear Dr. Stephen McQuaker, Director of Drug Development Consulting, as he explores case studies to demonstrate how drug substance and drug product development plans can be accelerated through innovative science and expertise to get drug substance off the critical path.

Lunch & Learn Seminar in Basel with Charles River and Quotient Sciences

Join experts from Charles River & Quotient Sciences for a complimentary lunch seminar in Basel, Switzerland on the 30th March. Please register early to avoid missing out!

Lunch & Learn Seminar in London with Charles River and Quotient Sciences

Join experts from Charles River & Quotient Sciences for a complimentary lunch seminar in London on the 28th March. Please register early to avoid missing out!

Quotient Sciences and Charles River Collaboration Webinar

Join experts from Quotient Sciences & Charles River for a webinar taking place on 18 May, "Integrated Strategies for Accelerating from Discovery to IND and Beyond: Charles River & Quotient Sciences Collaboration."

Drug Substance Synthesis and Manufacturing

Tactical deployment of best-in-class synthesis technologies to minimize chemistry costs and move your drug substance supply off the critical path.

Getting it Right Early: The Importance of Biopharmaceutics in Early Drug Development

Chris Roe, Quotient Sciences' Principal Research Fellow, discusses strategies for overcoming biopharmaceutic challenges for small molecules in today’s drug development.

Overcoming Complex Formulation Challenges Seminar | San Francisco

Register today for our upcoming happy hour seminar and reception in Burlingame, CA entitled: Overcoming Complex Formulation Challenges: Integrated Strategies for Poor Solubility, Modified Release & Pediatric

Get in touch
Humanity can’t afford to wait, so neither can we.
Let’s talk.